Investing Profile

Ela Borenstein

InvestorVC
Class 17 at Kauffman Fellows
Photo of Ela Borenstein, Kauffman Fellows

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Washington Applied Physics Laboratory Network
842 CONNECTIONS
University of Washington Applied Physics Laboratory Network
842 CONNECTIONS
University of Washington Applied Physics Laboratory Network
842 CONNECTIONS
University of Washington Applied Physics Laboratory Network
842 CONNECTIONS
University of Washington Applied Physics Laboratory Network
842 CONNECTIONS
cb
$2.0M - $5.0M
$3.5M
1
CompanyStageDateRound SizeTotal Raised
Milestone Pharmaceuticals
Series BJun 2015$17M
$72M
Co-investors: Marco Boorsma (Forbion), Debra K. Liebert (Domain Associates), Eric Linsley (Mission BioCapital)
Class 17 Kauffman Fellows2012 - Present
Vice President, Government Funds BDCPresent
Vice President Venture Capital Incentivized Programs BDCPresent
Program Director BDCPresent
Partner, Health Venture Fund BDCPresent
COO University of Washington Applied Physics LaboratoryPresent
VP, Reg Affairs/Product Strategy University of Washington Applied Physics LaboratoryPresent
VP, Regulatory and Clinical Affairs Theratechnologies Inc.Present
Senior VP, Scientific Affairs University of Washington Applied Physics LaboratoryPresent
Director, Clinical Research University of Washington Applied Physics LaboratoryPresent
Regulatory Affairs University of Washington Applied Physics LaboratoryPresent
Western University BSc Chemistry
University of Toronto MSc Pharmacology
Université du Québec à Montréal MBA BioIndustries
Western University bachelors, bachelor of science chemistry
University of Toronto master of science, masters pharmacology